{"id":"https://openalex.org/W2095445604","doi":"https://doi.org/10.1021/ml300110s","title":"Discovery of CX-5461, the First Direct and Selective Inhibitor of RNA Polymerase I, for Cancer Therapeutics","display_name":"Discovery of CX-5461, the First Direct and Selective Inhibitor of RNA Polymerase I, for Cancer Therapeutics","publication_year":2012,"publication_date":"2012-05-08","ids":{"openalex":"https://openalex.org/W2095445604","doi":"https://doi.org/10.1021/ml300110s","mag":"2095445604","pmid":"https://pubmed.ncbi.nlm.nih.gov/24900516","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4025669"},"language":"en","primary_location":{"id":"doi:10.1021/ml300110s","doi":"https://doi.org/10.1021/ml300110s","is_oa":false,"landing_page_url":"https://doi.org/10.1021/ml300110s","pdf_url":null,"source":{"id":"https://openalex.org/S191852912","display_name":"ACS Medicinal Chemistry Letters","issn_l":"1948-5875","issn":["1948-5875"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4025669","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089576016","display_name":"Mustapha Haddach","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Mustapha Haddach","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073291894","display_name":"Michael K. Schwaebe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael K. Schwaebe","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014463867","display_name":"Jerome Michaux","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jerome Michaux","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021286275","display_name":"Johnny Y. Nagasawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Johnny Nagasawa","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107430119","display_name":"Sean O\u2019Brien","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sean E. O'Brien","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112021855","display_name":"Jeffrey P. Whitten","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey P. Whitten","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112316914","display_name":"Fabrice Pierre","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fabrice Pierre","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006892984","display_name":"Pauline Kerdoncuff","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pauline Kerdoncuff","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066979115","display_name":"Levan Darjania","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Levan Darjania","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006718653","display_name":"Ryan K. Stansfield","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryan Stansfield","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050272324","display_name":"Denis Drygin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Denis Drygin","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018829106","display_name":"Kenna Lynn Anderes","orcid":"https://orcid.org/0000-0002-4515-2011","observed_orcids":["https://orcid.org/0000-0002-4515-2011"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenna Anderes","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073648232","display_name":"Chris Proffitt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chris Proffitt","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074653496","display_name":"Josh Bliesath","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Josh Bliesath","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038673041","display_name":"Adam Siddiqui-Jain","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adam Siddiqui-Jain","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012365333","display_name":"May Omori","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"May Omori","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016891210","display_name":"Nanni H. Huser","orcid":"https://orcid.org/0009-0005-8709-0903","observed_orcids":["https://orcid.org/0009-0005-8709-0903"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nanni Huser","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024503165","display_name":"William G. Rice","orcid":"https://orcid.org/0000-0001-5705-9474","observed_orcids":["https://orcid.org/0000-0001-5705-9474"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William G. Rice","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077836603","display_name":"David M. Ryckman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David M. Ryckman","raw_affiliation_strings":["Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5089576016"],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":1.367,"has_fulltext":false,"cited_by_count":170,"citation_normalized_percentile":{"value":0.770564,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"3","issue":"7","first_page":"602","last_page":"606"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.1574999988079071,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.1574999988079071,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10222","display_name":"Genomics and Chromatin Dynamics","score":0.12240000069141388,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.07370000332593918,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cx-5461","display_name":"CX-5461","score":1.0},{"id":"https://openalex.org/keywords/rna-polymerase-i-inhibition","display_name":"RNA polymerase I inhibition","score":0.8370000123977661},{"id":"https://openalex.org/keywords/anticancer-drug-discovery","display_name":"anticancer drug discovery","score":0.7239999771118164},{"id":"https://openalex.org/keywords/rrna-transcription","display_name":"rRNA transcription","score":0.7149999737739563},{"id":"https://openalex.org/keywords/ribosomal-dna-transcription","display_name":"ribosomal DNA transcription","score":0.777999997138977},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.6259999871253967},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.6240000128746033},{"id":"https://openalex.org/keywords/hematological-cancer","display_name":"hematologic cancer","score":0.6100000143051147},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.699999988079071}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5550287365913391},{"id":"https://openalex.org/C64350747","wikidata":"https://www.wikidata.org/wiki/Q15334993","display_name":"RNA polymerase II","level":5,"score":0.5021762847900391},{"id":"https://openalex.org/C179926584","wikidata":"https://www.wikidata.org/wiki/Q207714","display_name":"Transcription (linguistics)","level":2,"score":0.4997670650482178},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4725636839866638},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4717211127281189},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.45285090804100037},{"id":"https://openalex.org/C70916841","wikidata":"https://www.wikidata.org/wiki/Q3501658","display_name":"RNA polymerase III","level":5,"score":0.4513392448425293},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4218946397304535},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.42021989822387695},{"id":"https://openalex.org/C2776449523","wikidata":"https://www.wikidata.org/wiki/Q272631","display_name":"RNA polymerase","level":4,"score":0.3999260663986206},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3511802554130554},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3412415385246277},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.22691377997398376},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2032369077205658},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.16871485114097595},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.14587640762329102},{"id":"https://openalex.org/C101762097","wikidata":"https://www.wikidata.org/wiki/Q224093","display_name":"Promoter","level":4,"score":0.07136967778205872},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1021/ml300110s","doi":"https://doi.org/10.1021/ml300110s","is_oa":false,"landing_page_url":"https://doi.org/10.1021/ml300110s","pdf_url":null,"source":{"id":"https://openalex.org/S191852912","display_name":"ACS Medicinal Chemistry Letters","issn_l":"1948-5875","issn":["1948-5875"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3020234","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4025669","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:24900516","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24900516","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS medicinal chemistry letters","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4025669","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4025669/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Med Chem Lett","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:3020234","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4025669","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W70621156","https://openalex.org/W1855115129","https://openalex.org/W1896401624","https://openalex.org/W1980373840","https://openalex.org/W1991262449","https://openalex.org/W2010187254","https://openalex.org/W2049579102","https://openalex.org/W2057044337","https://openalex.org/W2076282684","https://openalex.org/W2076431837","https://openalex.org/W2076826746","https://openalex.org/W2076958652","https://openalex.org/W2077813812","https://openalex.org/W2092869829","https://openalex.org/W2100893053","https://openalex.org/W2100999034","https://openalex.org/W2103774926","https://openalex.org/W2123282517","https://openalex.org/W2135821923","https://openalex.org/W2146842824","https://openalex.org/W2161696113"],"related_works":["https://openalex.org/W2100893053","https://openalex.org/W6964394421","https://openalex.org/W2335766382","https://openalex.org/W3039867072","https://openalex.org/W2091494147","https://openalex.org/W4282934974","https://openalex.org/W4381414324","https://openalex.org/W3154836212","https://openalex.org/W2039978524","https://openalex.org/W2151510603"],"abstract_inverted_index":{"Accelerated":[0],"proliferation":[1],"of":[2,14,28,33,50,62,85,105,118],"solid":[3],"tumor":[4,42,95],"and":[5,44,54,81],"hematologic":[6],"cancer":[7,52],"cells":[8],"is":[9,46],"linked":[10],"to":[11,24],"accelerated":[12],"transcription":[13,89],"rDNA":[15],"by":[16,38],"the":[17,51,56,77,103],"RNA":[18,86],"polymerase":[19],"I":[20,64,88],"(Pol":[21],"I)":[22],"enzyme":[23],"produce":[25],"elevated":[26],"levels":[27],"rRNA":[29],"(rRNA).":[30],"Indeed,":[31],"upregulation":[32],"Pol":[34,63,87],"I,":[35],"frequently":[36],"caused":[37],"mutational":[39],"alterations":[40],"among":[41],"suppressors":[43],"oncogenes,":[45],"required":[47],"for":[48,58,113],"maintenance":[49],"phenotype":[53],"forms":[55],"basis":[57],"seeking":[59],"selective":[60],"inhibitors":[61],"as":[65,76,107],"anticancer":[66,109],"therapeutics.":[67],"2-(4-Methyl-[1,4]diazepan-1-yl)-5-oxo-5H-7-thia-1,11b-diaza-benzo[c]fluorene-6-carboxylic":[68],"acid":[69],"(5-methyl-pyrazin-2-ylmethyl)-amide":[70],"(CX-5461,":[71],"7c)":[72],"has":[73],"been":[74],"identified":[75],"first":[78],"potent,":[79],"selective,":[80],"orally":[82],"bioavailable":[83],"inhibitor":[84],"with":[90,111],"in":[91,94,115],"vivo":[92],"activity":[93,114],"growth":[96],"efficacy":[97],"models.":[98],"The":[99],"preclinical":[100],"data":[101],"support":[102],"development":[104],"CX-5461":[106],"an":[108],"drug":[110],"potential":[112],"several":[116],"types":[117],"cancer.":[119]},"counts_by_year":[{"year":2026,"cited_by_count":22},{"year":2025,"cited_by_count":14},{"year":2024,"cited_by_count":22},{"year":2023,"cited_by_count":17},{"year":2022,"cited_by_count":15},{"year":2021,"cited_by_count":21},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":5}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}